GB0916659D0 - Uses of behaviour and classification of homeostatic balances in cell systems - Google Patents

Uses of behaviour and classification of homeostatic balances in cell systems

Info

Publication number
GB0916659D0
GB0916659D0 GBGB0916659.6A GB0916659A GB0916659D0 GB 0916659 D0 GB0916659 D0 GB 0916659D0 GB 0916659 A GB0916659 A GB 0916659A GB 0916659 D0 GB0916659 D0 GB 0916659D0
Authority
GB
United Kingdom
Prior art keywords
homeostatic
balances
behaviour
classification
cell systems
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0916659.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GBGB0916659.6A priority Critical patent/GB0916659D0/en
Publication of GB0916659D0 publication Critical patent/GB0916659D0/en
Priority to PCT/GB2010/001789 priority patent/WO2011036453A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5026—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell morphology
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B99/00—Subject matter not provided for in other groups of this subclass

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Physiology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB0916659.6A 2009-09-22 2009-09-22 Uses of behaviour and classification of homeostatic balances in cell systems Ceased GB0916659D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0916659.6A GB0916659D0 (en) 2009-09-22 2009-09-22 Uses of behaviour and classification of homeostatic balances in cell systems
PCT/GB2010/001789 WO2011036453A1 (en) 2009-09-22 2010-09-22 Methods of analysing homeostatic state in cell systems

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0916659.6A GB0916659D0 (en) 2009-09-22 2009-09-22 Uses of behaviour and classification of homeostatic balances in cell systems

Publications (1)

Publication Number Publication Date
GB0916659D0 true GB0916659D0 (en) 2009-11-04

Family

ID=41327427

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0916659.6A Ceased GB0916659D0 (en) 2009-09-22 2009-09-22 Uses of behaviour and classification of homeostatic balances in cell systems

Country Status (2)

Country Link
GB (1) GB0916659D0 (en)
WO (1) WO2011036453A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018249444A1 (en) * 2017-04-03 2019-10-03 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for multiplexed quantitative analysis of cell lineages
CA3112211A1 (en) * 2018-10-02 2020-04-09 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for multiplexed quantitative analysis of cell lineages

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8103455B2 (en) * 2006-03-09 2012-01-24 Medical Research Council Method of assessing the proliferation or differentiation behaviour of a population of target cells in a biological system

Also Published As

Publication number Publication date
WO2011036453A1 (en) 2011-03-31

Similar Documents

Publication Publication Date Title
IL272848B (en) Methods for reprogramming cells and uses thereof
SG10201506767QA (en) Identification and enrichment of cell subpopulations
EP2391711A4 (en) Novel cell lines and methods
SG10201501551WA (en) Nanostructure and photovoltaic cell implementing same
GB2496558B (en) Solar cell and battery 3D integration
EP2376920A4 (en) Methods of detection of changes in cells
SI2579877T1 (en) Morpholino pyrimidines and their use in therapy
GB201206978D0 (en) Hydroisomerization and selective hydrogenation of feedstock in ionic liquid-catalyzed alkylation
GB201021244D0 (en) Improvements in and relating to aircraft
EP2486128A4 (en) Use of pedf in an encapsulated cell-based delivery system
IL214783A (en) Methods of reprogramming renal cells and renal cell populations obtained thereby
IL274395B (en) Subpopulations of spore-like cells and uses thereof
PL2451841T3 (en) Detection and visualization of the cell cycle in living cells
IL226761B (en) Membrane bound reporter molecules and their use in cell sorting
GB201014335D0 (en) Improvements in and relating to analysis
GB201017820D0 (en) Cells and devices
GB0908289D0 (en) Use of no and no donors for terminating dormancy in invertebrates
GB0916659D0 (en) Uses of behaviour and classification of homeostatic balances in cell systems
GB2486398B (en) Cell classification and artefact rejection for cell nuclei
GB201020368D0 (en) Improvements in and relating to fall protection systems
GB201019850D0 (en) Improvements in monitoring and tracking vehicles
PL2524030T3 (en) Organ-specific feline endothelial cells and uses
GB201116352D0 (en) Improvements in or relating to container arrangements and container systems
EP2491388A4 (en) Cell free cd4 quantitation and methods of use
GB201012052D0 (en) Glyco-engineering in lower eukaryotic cells

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)